Jacobi Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Jacobi Capital Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$3K	–	1037
2018 Q3	$3K	Hold	1,000	–	–	﹤0.01%	880
2018 Q2	$4K	Hold	1,000	–	–	﹤0.01%	863
2018 Q1	$4K	Hold	1,000	–	–	﹤0.01%	845
2017 Q4	$5K	Hold	1,000	–	–	﹤0.01%	793
2017 Q3	$8K	Hold	1,000	–	–	﹤0.01%	687
2017 Q2	$8K	Hold	1,000	–	–	﹤0.01%	619
2017 Q1	$6K	Buy	+1,000	New	+$5.48K	﹤0.01%	537
2016 Q4	–	Sell	-1,000	Closed	-$5K	–	749
2016 Q3	$5K	Hold	1,000	–	–	﹤0.01%	569
2016 Q2	$7K	Buy	+1,000	New	+$5.59K	﹤0.01%	515

Jacobi Capital Management's KERX Position: Q4 2018 in Review

Jacobi Capital Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 1,000 shares — an estimated $3K sold.

Jacobi Capital Management first reported a position in KERX in Q2 2016 and held it in 9 quarters. The position peaked at $8K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Jacobi Capital Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Jacobi Capital Management sold 1,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $3K.
Jacobi Capital Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2016 and held it in 9 quarters.
Jacobi Capital Management's Keryx Biopharmaceuticals Inc position peaked at $8K in Q3 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Jacobi Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.